Twenty years of clinical islet transplantation at the Diabetes Research Institute--University of Miami.

Antonello Pileggi; Camillo Ricordi; Norma S. Kenyon; Tatiana Froud; David A. Baidal; Aisha Kahn; Gennaro Selvaggi; Rodolfo Alejandro

Twenty years of clinical islet transplantation at the Diabetes Research Institute--University of Miami.

Antonello Pileggi, Camillo Ricordi, Norma S. Kenyon, Tatiana Froud, David A. Baidal, Aisha Kahn, Gennaro Selvaggi, Rodolfo Alejandro

Research output: Contribution to journal › Review article › peer-review

41 Scopus citations

Abstract

Transplantation of allogeneic pancreatic islets for the treatment of patients with Type 1 diabetes mellitus (T1DM) is now a reality. The steady progress that has allowed for the recent successful clinical trials world-wide follows a steep learning curve and the perseverance of the international islet transplantation community. The Clinical Islet Transplant Program at the Diabetes Research Institute - University of Miami has contributed to the progress in the field with a 20-year track record. It has been a long journey and despite the intermediate success, more work is needed in order to achieve the ultimate goal of a safe and long-lasting treatment for patients with T1DM.

Original language	English (US)
Pages (from-to)	177-204
Number of pages	28
Journal	Clinical transplants
State	Published - 2004

ASJC Scopus subject areas

Medicine(all)

Fingerprint Dive into the research topics of 'Twenty years of clinical islet transplantation at the Diabetes Research Institute--University of Miami.'. Together they form a unique fingerprint.

Cite this

@article{fe48e5eb22a7446293685407806704ae,

title = "Twenty years of clinical islet transplantation at the Diabetes Research Institute--University of Miami.",

abstract = "Transplantation of allogeneic pancreatic islets for the treatment of patients with Type 1 diabetes mellitus (T1DM) is now a reality. The steady progress that has allowed for the recent successful clinical trials world-wide follows a steep learning curve and the perseverance of the international islet transplantation community. The Clinical Islet Transplant Program at the Diabetes Research Institute - University of Miami has contributed to the progress in the field with a 20-year track record. It has been a long journey and despite the intermediate success, more work is needed in order to achieve the ultimate goal of a safe and long-lasting treatment for patients with T1DM.",

author = "Antonello Pileggi and Camillo Ricordi and Kenyon, {Norma S.} and Tatiana Froud and Baidal, {David A.} and Aisha Kahn and Gennaro Selvaggi and Rodolfo Alejandro",

note = "Copyright: This record is sourced from MEDLINE{\textregistered}/PubMed{\textregistered}, a database of the U.S. National Library of Medicine",

year = "2004",

language = "English (US)",

pages = "177--204",

journal = "Clinical transplants",

issn = "0890-9016",

publisher = "UCLA Immunogenetics Center",

}

TY - JOUR

T1 - Twenty years of clinical islet transplantation at the Diabetes Research Institute--University of Miami.

AU - Pileggi, Antonello

AU - Ricordi, Camillo

AU - Kenyon, Norma S.

AU - Froud, Tatiana

AU - Baidal, David A.

AU - Kahn, Aisha

AU - Selvaggi, Gennaro

AU - Alejandro, Rodolfo

N1 - Copyright: This record is sourced from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

PY - 2004

Y1 - 2004

N2 - Transplantation of allogeneic pancreatic islets for the treatment of patients with Type 1 diabetes mellitus (T1DM) is now a reality. The steady progress that has allowed for the recent successful clinical trials world-wide follows a steep learning curve and the perseverance of the international islet transplantation community. The Clinical Islet Transplant Program at the Diabetes Research Institute - University of Miami has contributed to the progress in the field with a 20-year track record. It has been a long journey and despite the intermediate success, more work is needed in order to achieve the ultimate goal of a safe and long-lasting treatment for patients with T1DM.

AB - Transplantation of allogeneic pancreatic islets for the treatment of patients with Type 1 diabetes mellitus (T1DM) is now a reality. The steady progress that has allowed for the recent successful clinical trials world-wide follows a steep learning curve and the perseverance of the international islet transplantation community. The Clinical Islet Transplant Program at the Diabetes Research Institute - University of Miami has contributed to the progress in the field with a 20-year track record. It has been a long journey and despite the intermediate success, more work is needed in order to achieve the ultimate goal of a safe and long-lasting treatment for patients with T1DM.

UR - http://www.scopus.com/inward/record.url?scp=33745280058&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745280058&partnerID=8YFLogxK

M3 - Review article

C2 - 16704150

AN - SCOPUS:33745280058

SP - 177

EP - 204

JO - Clinical transplants

JF - Clinical transplants

SN - 0890-9016

ER -